Price Alert

Taro Pharmaceutical Indus... (TARO)

NYSE: TARO · Real-Time Price · USD

42.98

0.01 (0.02%)

At close: Jun 21, 2024, 9:59 PM

Taro Pharmaceutical Industries Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Cash & Equivalents	362.91M	382.41M	269.01M	124.17M	154.5M	91.97M	175.19M	225.8M	251.13M	318.1M	523.67M	614.89M	605.18M	552.92M	498.8M	532.04M
Short-Term Investments	516.44M	519.81M	638.04M	681.99M	695.79M	771.92M	664.3M	580.45M	569.61M	468.98M	448.89M	410.59M	418.48M	521.04M	543.2M	590.29M
Long-Term Investments	457.99M	403.54M	388.37M	451.17M	404.9M	337.43M	357.59M	374.97M	435.19M	536.35M	552.94M	568.88M	557.21M	476.25M	476.8M	510.4M
Other Long-Term Assets	82.45M	79.31M	80.62M	81.5M	83.15M	-121.1M	64.71M	65.66M	6.77M	29.78M	30.19M	30.8M	4.34M	32.21M	32.26M	31.74M
Receivables	177.46M	230.37M	227.32M	283.43M	241.8M	251.81M	301.59M	325.19M	306.7M	267.71M	256.46M	272.43M	266.89M	278.79M	276.62M	234.38M
Inventory	204.82M	214.82M	208.19M	204.59M	226.67M	222.68M	215.52M	216.83M	210.44M	182.45M	182.93M	182.86M	180.29M	169.53M	167.21M	166.22M
Other Current Assets	41.77M	39.14M	46.25M	56.55M	11.72M	51.73M	53.1M	347.77M	14.22M	303.29M	292.03M	272.43M	14.03M	49.96M	276.62M	234.38M
Total Current Assets	1.3B	1.35B	1.34B	1.29B	1.34B	1.39B	1.36B	1.35B	1.34B	1.24B	1.41B	1.48B	1.47B	1.52B	1.49B	1.52B
Property-Plant & Equipment	217.59M	218.38M	189.89M	189.59M	190.14M	190.51M	191.49M	194.81M	199.69M	194M	196.63M	202.03M	205.51M	206.3M	207.92M	209.23M
Goodwill & Intangibles	17.23M	17.23M	17.23M	17.23M	17.23M	12.72M	12.72M	12.72M	71.94M	n/a	n/a	n/a	26.98M	n/a	n/a	n/a
Total Long-Term Assets	858.67M	815.77M	776.92M	840.88M	799.09M	540.66M	750.67M	771.73M	838.48M	885.78M	905.21M	932.54M	936.04M	849.55M	860.28M	856.76M
Total Assets	2.16B	2.16B	2.12B	2.14B	2.14B	2.12B	2.11B	2.12B	2.18B	2.12B	2.32B	2.41B	2.41B	2.37B	2.35B	2.38B
Account Payables	44.66M	51.18M	43.06M	59.37M	68.48M	69.55M	61.36M	73.92M	68.23M	43.69M	55.23M	62.07M	61.17M	45.41M	39.97M	36.3M
Deferred Revenue	n/a	n/a	n/a	n/a	903K	n/a	n/a	123.57M	5.79M	125.66M	125.45M	130.83M	7.58M	n/a	143.3M	105.39M
Short-Term Debt	n/a	n/a	n/a	n/a	1.95M	n/a	n/a	n/a	2.2M	n/a	n/a	n/a	1.69M	n/a	n/a	n/a
Other Current Liabilities	316.44M	322.88M	318.43M	325.64M	314.21M	304.53M	313.5M	300.53M	355.89M	351.11M	558.73M	667.08M	605.86M	538.67M	547.35M	560.18M
Total Current Liabilities	361.11M	374.06M	361.49M	385.01M	385.55M	374.07M	374.85M	374.45M	432.12M	394.79M	613.96M	729.15M	676.3M	584.08M	587.32M	596.49M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	7.96M	10.03M	10.43M	11.51M	-616K	23.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	7.96M	10.03M	10.43M	11.51M	19.11M	-69.55M	26.15M	31.83M	32.8M	31.67M	30.09M	26.1M	35.12M	37.17M	40.05M	109.07M
Total Liabilities	369.06M	384.09M	371.92M	396.52M	404.65M	397.59M	401M	406.28M	464.92M	426.46M	644.05M	755.25M	711.42M	621.25M	627.36M	705.55M
Total Debt	n/a	n/a	n/a	n/a	1.95M	n/a	n/a	n/a	2.2M	n/a	n/a	n/a	1.69M	n/a	n/a	n/a
Common Stock	1.79B	1.78B	1.75B	1.74B	680K	1.72B	1.71B	1.71B	680K	1.7B	1.67B	1.66B	679K	1.76B	1.73B	1.68B
Retained Earnings	n/a	n/a	n/a	n/a	2.41B	n/a	n/a	n/a	2.39B	n/a	n/a	n/a	2.34B	n/a	n/a	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	-175M	n/a	n/a	n/a	-168.97M	n/a	n/a	n/a	-151.62M	n/a	n/a	3.37B
Shareholders Equity	1.79B	1.78B	1.75B	1.74B	1.73B	1.72B	1.71B	1.71B	1.71B	1.7B	1.67B	1.66B	1.7B	1.76B	1.73B	1.68B
Total Investments	974.43M	923.35M	1.03B	1.13B	1.1B	1.11B	1.02B	955.41M	1B	1.01B	1B	979.47M	975.69M	997.29M	1.02B	1.1B